Word

LYSRUPTO

Status

Pending

Status Code

731

Status Date

Wednesday, November 15, 2023

Serial Number

97129252

Mark Type

4000

Filing Date

Wednesday, November 17, 2021

Published for Opposition

Tuesday, October 4, 2022

Trademark Owner History

Contrafect Corporation - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of Gram-positive bacterial infection, including, but not limited to, Staphylococcus aureus infection; pharmaceutical preparations for the treatment of drug-resistant strains of bacteria, including antibiotic-resistance bacterial infection; and pharmaceutical preparations for the treatment of infections related to Gram-positive bacteria and drug-resistant strains of bacteria, including, but not limited to, Staphylococcus aureus blood stream infections, Staphylococcus aureus bacteremia and endocarditis, including, but not limited to, right-sided infective endocarditis, including right-sided infective endocarditis caused by methicillin-susceptible and methicillin-resistant isolates

Trademark Events

Nov 17, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 15, 2023

Sou Extension 2 Granted

Nov 15, 2023

Sou Extension 2 Filed

Nov 15, 2023

Sou Teas Extension Received

Oct 17, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Oct 17, 2023

Teas Change Of Correspondence Received

Oct 17, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 17, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 30, 2023

Notice Of Approval Of Extension Request E-Mailed

May 26, 2023

Sou Extension 1 Granted

May 26, 2023

Sou Extension 1 Filed

May 26, 2023

Sou Teas Extension Received

Nov 29, 2022

Noa E-Mailed - Sou Required From Applicant

Oct 4, 2022

Official Gazette Publication Confirmation E-Mailed

Oct 4, 2022

Published For Opposition

Sep 14, 2022

Notification Of Notice Of Publication E-Mailed

Aug 30, 2022

Approved For Pub - Principal Register

Aug 30, 2022

Examiner's Amendment Entered

Aug 30, 2022

Notification Of Examiners Amendment E-Mailed

Aug 30, 2022

Examiners Amendment E-Mailed

Aug 30, 2022

Examiners Amendment -Written

Aug 29, 2022

Assigned To Examiner

Nov 22, 2021

New Application Office Supplied Data Entered

Nov 20, 2021

New Application Entered